| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Zheng John Shen is Director at VICR. Zheng John Shen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Zheng John Shen has 7 Form 4 filings on record from June 2022 to June 2026, all as Director at Vicor (VICR), 2022–2026.
The 11 reported transactions were 5 option or other derivative awards, 3 option exercises and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $691K.
The largest open-market sale was 2,503 shares of VICR at an average $175.96 on February 23, 2026, about $440K.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.